Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Opioids | Research

Analysis of physical activity and prescription opioid use among US adults: a cross-sectional study

Authors: Junpeng Wu, Panpan Yang, Xiaodan Wu, Xiaoxuan Yu, Fanfang Zeng, Haitang Wang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Opioid crisis has become a global concern, but whether physical activity (PA) can effectively reduce prescription opioid use remains unclear. The study aimed to examine the relationship of different domains of PA (e.g., occupation-related PA [OPA], transportation-related PA [TPA], leisure-time PA [LTPA]) with prescription opioid use and duration of prescription opioid use.

Methods

This cross-sectional study was conducted on 27,943 participants aged ≥ 18 years from National Health and Nutrition Examination Survey (NHANES, 2007– March 2020). We examined the relationship of different domains of PA with prescription opioid use and duration of prescription opioid use using multivariable logistic regression. Stratified analysis and a series of sensitivity analysis were used to elevate robustness. All analyses were conducted using appropriate sampling weights.

Results

Of the 27,943 participants, the mean age was 45.10 years, with 14,018 [weighted, 50.0%] females and 11,045 [weighted, 66.0%] non-Hispanic White. After multivariable adjustment, inverse associations between PA and prescription opioid use were observed for sufficient (≥ 150 min/week) total PA (OR,0.68 95%CI [0.56–0.81]), TPA (OR,0.73 95%CI [0.58–0.92]), and LTPA (OR,0.60 95%CI [0.48–0.75]) compared with insufficient PA(< 150 min/week), but not for sufficient OPA (OR,0.93 95%CI [0.79–1.10]). In addition, the associations were dose-responsive, participants had 22–40%, 27–36%, and 26–47% lower odds of using prescription opioids depending on the duration of total PA, TPA, and LTPA, respectively. Nevertheless, the impact of PA on prescription opioid use varied by duration of opioid use. Sufficient total PA was associated with elevated odds of short-term use of prescription opioids (< 90 days). Comparatively, sufficient total PA, TPA, and LTPA had different beneficial effects on reducing long-term use of prescription opioids (≥ 90 days) depending on the strength of opioids.

Conclusions

This study demonstrated sufficient total PA, TPA, and LTPA were inversely associated with prescription opioid use and varied depending on the duration and strength of prescription opioid use. These findings highlight PA can provide policy guidance to address opioid crisis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep. 2022;71(3):1.PubMedPubMedCentralCrossRef Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep. 2022;71(3):1.PubMedPubMedCentralCrossRef
2.
go back to reference Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Med. 2015;16(suppl_1):S3–8.PubMedCrossRef Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Med. 2015;16(suppl_1):S3–8.PubMedCrossRef
3.
go back to reference Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Phys. 2010;13(5):401–35.CrossRef Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Phys. 2010;13(5):401–35.CrossRef
5.
go back to reference Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91(2):199–211.PubMedCrossRef Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91(2):199–211.PubMedCrossRef
6.
go back to reference Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–25.PubMedCrossRef Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–25.PubMedCrossRef
7.
go back to reference Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 2003;63(7):649–71.PubMedCrossRef Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 2003;63(7):649–71.PubMedCrossRef
8.
go back to reference Sun M, Lin JA, Chang CL, Wu SY, Zhang J. Association between long-term opioid use and cancer risk in patients with chronic pain: a propensity score-matched cohort study. Br J Anaesth. 2022;129(1):84–91.PubMedCrossRef Sun M, Lin JA, Chang CL, Wu SY, Zhang J. Association between long-term opioid use and cancer risk in patients with chronic pain: a propensity score-matched cohort study. Br J Anaesth. 2022;129(1):84–91.PubMedCrossRef
9.
go back to reference Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerda M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Netw Open. 2019;2(1):e186007.PubMedPubMedCentralCrossRef Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerda M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Netw Open. 2019;2(1):e186007.PubMedPubMedCentralCrossRef
10.
go back to reference Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7(1):13–21.PubMedPubMedCentralCrossRef Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7(1):13–21.PubMedPubMedCentralCrossRef
11.
go back to reference Baron RB. Treating blood pressure correctly by measuring it correctly. JAMA Intern Med. 2018;178(6):860–1.PubMedCrossRef Baron RB. Treating blood pressure correctly by measuring it correctly. JAMA Intern Med. 2018;178(6):860–1.PubMedCrossRef
12.
go back to reference Sandhu H, Underwood M, Furlan AD, Noyes J, Eldabe S. What interventions are effective to taper opioids in patients with chronic pain? BMJ. 2018;362:k2990.PubMedCrossRef Sandhu H, Underwood M, Furlan AD, Noyes J, Eldabe S. What interventions are effective to taper opioids in patients with chronic pain? BMJ. 2018;362:k2990.PubMedCrossRef
13.
go back to reference Hankinson AL, Daviglus ML, Bouchard C, Carnethon M, Lewis CE, Schreiner PJ, Liu K, Sidney S. Maintaining a high physical activity level over 20 years and weight gain. JAMA. 2010;304(23):2603–10.PubMedCrossRef Hankinson AL, Daviglus ML, Bouchard C, Carnethon M, Lewis CE, Schreiner PJ, Liu K, Sidney S. Maintaining a high physical activity level over 20 years and weight gain. JAMA. 2010;304(23):2603–10.PubMedCrossRef
14.
go back to reference White RL, Babic MJ, Parker PD, Lubans DR, Astell-Burt T, Lonsdale C. Domain-specific physical activity and mental health: a meta-analysis. Am J Prev Med. 2017;52(5):653–66.PubMedCrossRef White RL, Babic MJ, Parker PD, Lubans DR, Astell-Burt T, Lonsdale C. Domain-specific physical activity and mental health: a meta-analysis. Am J Prev Med. 2017;52(5):653–66.PubMedCrossRef
15.
go back to reference Fjeld MK, Årnes AP, Engdahl B, Morseth B, Hopstock LA, Horsch A, Stubhaug A, Strand BH, Nielsen CS, Steingrímsdóttir ÓA. Consistent pattern between physical activity measures and chronic pain levels: the Tromsø Study 2015 to 2016. Pain. 2023;164(4):838–47.PubMedCrossRef Fjeld MK, Årnes AP, Engdahl B, Morseth B, Hopstock LA, Horsch A, Stubhaug A, Strand BH, Nielsen CS, Steingrímsdóttir ÓA. Consistent pattern between physical activity measures and chronic pain levels: the Tromsø Study 2015 to 2016. Pain. 2023;164(4):838–47.PubMedCrossRef
16.
go back to reference Rosoff DB, Smith GD, Lohoff FW. Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders. JAMA Psychiatry. 2021;78(2):151–60.PubMedCrossRef Rosoff DB, Smith GD, Lohoff FW. Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders. JAMA Psychiatry. 2021;78(2):151–60.PubMedCrossRef
17.
go back to reference Stokes A, Lundberg DJ, Sheridan B, Hempstead K, Morone NE, Lasser KE, Trinquart L, Neogi T. Association of obesity with prescription opioids for painful conditions in patients seeking primary care in the US. JAMA Netw Open. 2020;3(4):e202012.PubMedPubMedCentralCrossRef Stokes A, Lundberg DJ, Sheridan B, Hempstead K, Morone NE, Lasser KE, Trinquart L, Neogi T. Association of obesity with prescription opioids for painful conditions in patients seeking primary care in the US. JAMA Netw Open. 2020;3(4):e202012.PubMedPubMedCentralCrossRef
18.
go back to reference MacLean RR, Spinola S, Manhapra A, Sofuoglu M. Systematic review of pain severity and opioid craving in chronic pain and opioid use disorder. Pain Med. 2020;21(2):e146–63.PubMed MacLean RR, Spinola S, Manhapra A, Sofuoglu M. Systematic review of pain severity and opioid craving in chronic pain and opioid use disorder. Pain Med. 2020;21(2):e146–63.PubMed
19.
go back to reference Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The physical activity guidelines for Americans. Jama. 2018;320(19):2020–8.PubMedPubMedCentralCrossRef Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The physical activity guidelines for Americans. Jama. 2018;320(19):2020–8.PubMedPubMedCentralCrossRef
20.
go back to reference Katzmarzyk PT, Friedenreich C, Shiroma EJ, Lee IM. Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries. Br J Sports Med. 2022;56(2):101–6.PubMedCrossRef Katzmarzyk PT, Friedenreich C, Shiroma EJ, Lee IM. Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries. Br J Sports Med. 2022;56(2):101–6.PubMedCrossRef
21.
go back to reference Votruba SB, Holtermann A, Marott JL, Gyntelberg F, Søgaard K, Suadicani P, Mortensen OS, Prescott E, Schnohr P. Does the benefit on survival from leisure time physical activity depend on physical activity at work? A prospective cohort study. PLoS One. 2013;8(1):e54548.ADSCrossRef Votruba SB, Holtermann A, Marott JL, Gyntelberg F, Søgaard K, Suadicani P, Mortensen OS, Prescott E, Schnohr P. Does the benefit on survival from leisure time physical activity depend on physical activity at work? A prospective cohort study. PLoS One. 2013;8(1):e54548.ADSCrossRef
22.
go back to reference Holtermann A, Schnohr P, Nordestgaard BG, Marott JL. The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults. Eur Heart J. 2021;42(15):1499–511.PubMedPubMedCentralCrossRef Holtermann A, Schnohr P, Nordestgaard BG, Marott JL. The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults. Eur Heart J. 2021;42(15):1499–511.PubMedPubMedCentralCrossRef
23.
go back to reference Umeda M, Kim Y. Gender differences in the prevalence of chronic pain and leisure time physical activity among US adults: a NHANES study. Int J Environ Res Public Health. 2019;16(6):988.PubMedPubMedCentralCrossRef Umeda M, Kim Y. Gender differences in the prevalence of chronic pain and leisure time physical activity among US adults: a NHANES study. Int J Environ Res Public Health. 2019;16(6):988.PubMedPubMedCentralCrossRef
24.
go back to reference Søgaard K, Sjøgaard G. Physical activity as cause and cure of muscular pain: evidence of underlying mechanisms. Exerc Sport Sci Rev. 2017;45(3):136–45.PubMedPubMedCentralCrossRef Søgaard K, Sjøgaard G. Physical activity as cause and cure of muscular pain: evidence of underlying mechanisms. Exerc Sport Sci Rev. 2017;45(3):136–45.PubMedPubMedCentralCrossRef
25.
go back to reference Heneweer H, Staes F, Aufdemkampe G, van Rijn M, Vanhees L. Physical activity and low back pain: a systematic review of recent literature. Eur Spine J. 2011;20(6):826–45.PubMedPubMedCentralCrossRef Heneweer H, Staes F, Aufdemkampe G, van Rijn M, Vanhees L. Physical activity and low back pain: a systematic review of recent literature. Eur Spine J. 2011;20(6):826–45.PubMedPubMedCentralCrossRef
26.
go back to reference Psarianos A, Chryssanthopoulos C, Paparrigopoulos T, Philippou A. The role of physical exercise in opioid substitution therapy: mechanisms of sequential effects. Int J Mol Sci. 2023;24(5):4763.PubMedPubMedCentralCrossRef Psarianos A, Chryssanthopoulos C, Paparrigopoulos T, Philippou A. The role of physical exercise in opioid substitution therapy: mechanisms of sequential effects. Int J Mol Sci. 2023;24(5):4763.PubMedPubMedCentralCrossRef
27.
go back to reference Beitel M, Stults-Kolehmainen M, Cutter CJ, Schottenfeld RS, Eggert K, Madden LM, Kerns RD, Liong C, Ginn J, Barry DT. Physical activity, psychiatric distress, and interest in exercise group participation among individuals seeking methadone maintenance treatment with and without chronic pain. Am J Addict. 2016;25(2):125–31.PubMedCrossRef Beitel M, Stults-Kolehmainen M, Cutter CJ, Schottenfeld RS, Eggert K, Madden LM, Kerns RD, Liong C, Ginn J, Barry DT. Physical activity, psychiatric distress, and interest in exercise group participation among individuals seeking methadone maintenance treatment with and without chronic pain. Am J Addict. 2016;25(2):125–31.PubMedCrossRef
28.
go back to reference Caviness CM, Bird JL, Anderson BJ, Abrantes AM, Stein MD. Minimum recommended physical activity, and perceived barriers and benefits of exercise in methadone maintained persons. J Subst Abuse Treat. 2013;44(4):457–62.PubMedCrossRef Caviness CM, Bird JL, Anderson BJ, Abrantes AM, Stein MD. Minimum recommended physical activity, and perceived barriers and benefits of exercise in methadone maintained persons. J Subst Abuse Treat. 2013;44(4):457–62.PubMedCrossRef
29.
go back to reference Bernard DM, Encinosa W, Cohen J, Fang Z. Patient factors that affect opioid use among adults with and without chronic pain. Res Social Adm Pharm. 2021;17(6):1059–65.PubMedCrossRef Bernard DM, Encinosa W, Cohen J, Fang Z. Patient factors that affect opioid use among adults with and without chronic pain. Res Social Adm Pharm. 2021;17(6):1059–65.PubMedCrossRef
30.
go back to reference Carpenter RW, Acuff SF, Meshesha LZ. The role of environmental context and physical activity in prescribed opioid use and pain in daily life among patients with chronic low back pain. Ann Behav Med. 2023;57(7):541–50.PubMedCrossRef Carpenter RW, Acuff SF, Meshesha LZ. The role of environmental context and physical activity in prescribed opioid use and pain in daily life among patients with chronic low back pain. Ann Behav Med. 2023;57(7):541–50.PubMedCrossRef
31.
go back to reference Akinbami LJ, Chen T-C, Davy O, Ogden CL, Fink S, Clark J, Riddles MK, Mohadjer LK. National health and nutrition examination survey, 2017–March 2020 prepandemic file: sample design, estimation, and analytic guidelines. 2022. Akinbami LJ, Chen T-C, Davy O, Ogden CL, Fink S, Clark J, Riddles MK, Mohadjer LK. National health and nutrition examination survey, 2017–March 2020 prepandemic file: sample design, estimation, and analytic guidelines. 2022.
32.
go back to reference Divney AA, Murillo R, Rodriguez F, Mirzayi CA, Tsui EK, Echeverria SE. diabetes prevalence by leisure-, transportation-, and occupation-based physical activity among racially/ethnically diverse U.S. adults. Diabetes Care. 2019;42(7):1241–7.PubMedPubMedCentralCrossRef Divney AA, Murillo R, Rodriguez F, Mirzayi CA, Tsui EK, Echeverria SE. diabetes prevalence by leisure-, transportation-, and occupation-based physical activity among racially/ethnically diverse U.S. adults. Diabetes Care. 2019;42(7):1241–7.PubMedPubMedCentralCrossRef
33.
go back to reference Mojtabai R. National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2018;27(5):526–34.PubMedCrossRef Mojtabai R. National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2018;27(5):526–34.PubMedCrossRef
34.
go back to reference Stokes A, Berry KM, Collins JM, Hsiao CW, Waggoner JR, Johnston SS, Ammann EM, Scamuffa RF, Lee S, Lundberg DJ, et al. The contribution of obesity to prescription opioid use in the United States. Pain. 2019;160(10):2255–62.PubMedPubMedCentralCrossRef Stokes A, Berry KM, Collins JM, Hsiao CW, Waggoner JR, Johnston SS, Ammann EM, Scamuffa RF, Lee S, Lundberg DJ, et al. The contribution of obesity to prescription opioid use in the United States. Pain. 2019;160(10):2255–62.PubMedPubMedCentralCrossRef
35.
go back to reference Frenk SM, Porter KS, Paulozzi L. Prescription opioid analgesic use among adults: United States, 1999–2012: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2015. Frenk SM, Porter KS, Paulozzi L. Prescription opioid analgesic use among adults: United States, 1999–2012: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2015.
36.
go back to reference Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA. Inverse association of telomere length with liver disease and mortality in the US population. Hepatol Commun. 2022;6(2):399–410.PubMedCrossRef Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA. Inverse association of telomere length with liver disease and mortality in the US population. Hepatol Commun. 2022;6(2):399–410.PubMedCrossRef
37.
go back to reference Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study. Ann Intern Med. 2021;174(2):167–74.PubMedCrossRef Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study. Ann Intern Med. 2021;174(2):167–74.PubMedCrossRef
38.
go back to reference Birke H, Ekholm O, Sjøgren P, Kurita GP, Højsted J. Long-term opioid therapy in Denmark: a disappointing journey. Eur J Pain. 2017;21(9):1516–27.PubMedCrossRef Birke H, Ekholm O, Sjøgren P, Kurita GP, Højsted J. Long-term opioid therapy in Denmark: a disappointing journey. Eur J Pain. 2017;21(9):1516–27.PubMedCrossRef
39.
go back to reference Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain. Pain. 2006;125(1):172–9.PubMedCrossRef Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain. Pain. 2006;125(1):172–9.PubMedCrossRef
40.
go back to reference Roessler KK. Exercise treatment for drug abuse - A Danish pilot study. Scand J Public Health. 2010;38(6):664–9.PubMedCrossRef Roessler KK. Exercise treatment for drug abuse - A Danish pilot study. Scand J Public Health. 2010;38(6):664–9.PubMedCrossRef
41.
go back to reference Joseph SA, Chiu Y-HM, Tracy K. Risk factors for inappropriate opioid use among New York City residents. Curr Psychol. 2021;42(9):7649–58.CrossRef Joseph SA, Chiu Y-HM, Tracy K. Risk factors for inappropriate opioid use among New York City residents. Curr Psychol. 2021;42(9):7649–58.CrossRef
42.
go back to reference Thorlund JB, Roos EM, Goro P, Ljungcrantz EG, Grønne DT, Skou ST. Patients use fewer analgesics following supervised exercise therapy and patient education: an observational study of 16 499 patients with knee or hip osteoarthritis. Br J Sports Med. 2021;55(12):670–5.PubMedCrossRef Thorlund JB, Roos EM, Goro P, Ljungcrantz EG, Grønne DT, Skou ST. Patients use fewer analgesics following supervised exercise therapy and patient education: an observational study of 16 499 patients with knee or hip osteoarthritis. Br J Sports Med. 2021;55(12):670–5.PubMedCrossRef
43.
go back to reference Johansson MS, Pottegård A, Søndergaard J, Englund M, Grønne DT, Skou ST, Roos EM, Thorlund JB. Chronic opioid use before and after exercise therapy and patient education among patients with knee or hip osteoarthritis. Osteoarthritis Cartilage. 2022;30(11):1536–44.PubMedCrossRef Johansson MS, Pottegård A, Søndergaard J, Englund M, Grønne DT, Skou ST, Roos EM, Thorlund JB. Chronic opioid use before and after exercise therapy and patient education among patients with knee or hip osteoarthritis. Osteoarthritis Cartilage. 2022;30(11):1536–44.PubMedCrossRef
44.
go back to reference Hosseini M, Alaei HA, Naderi A, Sharifi MR, Zahed R. Treadmill exercise reduces self-administration of morphine in male rats. Pathophysiology. 2009;16(1):3–7.PubMedCrossRef Hosseini M, Alaei HA, Naderi A, Sharifi MR, Zahed R. Treadmill exercise reduces self-administration of morphine in male rats. Pathophysiology. 2009;16(1):3–7.PubMedCrossRef
45.
go back to reference Andrews NE, Strong J, Meredith PJ, Fleming JA. The relationship between overactivity and opioid use in chronic pain. Pain. 2016;157(2):466–74.PubMedCrossRef Andrews NE, Strong J, Meredith PJ, Fleming JA. The relationship between overactivity and opioid use in chronic pain. Pain. 2016;157(2):466–74.PubMedCrossRef
46.
go back to reference Andrews NE, Strong J, Meredith PJ, Gordon K, Bagraith KS. It’s very hard to change yourself. Pain. 2015;156(7):1215–31.PubMedCrossRef Andrews NE, Strong J, Meredith PJ, Gordon K, Bagraith KS. It’s very hard to change yourself. Pain. 2015;156(7):1215–31.PubMedCrossRef
47.
go back to reference Matei D, Trofin D, Iordan DA, Onu I, Condurache I, Ionite C, Buculei I. The endocannabinoid system and physical exercise. Int J Mol Sci. 2023;24(3):1989.PubMedPubMedCentralCrossRef Matei D, Trofin D, Iordan DA, Onu I, Condurache I, Ionite C, Buculei I. The endocannabinoid system and physical exercise. Int J Mol Sci. 2023;24(3):1989.PubMedPubMedCentralCrossRef
48.
go back to reference Goldfarb AH. Exercise and endogenous opiates. In: Endocrinology of Physical Activity and Sport: Second Edition. edn. Totowa: Humana Press, Springer; 2013. p. 21–36. Goldfarb AH. Exercise and endogenous opiates. In: Endocrinology of Physical Activity and Sport: Second Edition. edn. Totowa: Humana Press, Springer; 2013. p. 21–36.
49.
go back to reference Rosa HZ, Barcelos RCS, Segat HJ, Roversi K, Dias VT, Milanesi LH, Burger ME. Physical exercise modifies behavioral and molecular parameters related to opioid addiction regardless of training time. Eur Neuropsychopharmacol. 2020;32:25–35.PubMedCrossRef Rosa HZ, Barcelos RCS, Segat HJ, Roversi K, Dias VT, Milanesi LH, Burger ME. Physical exercise modifies behavioral and molecular parameters related to opioid addiction regardless of training time. Eur Neuropsychopharmacol. 2020;32:25–35.PubMedCrossRef
50.
go back to reference Robison LS, Swenson S, Hamilton J, Thanos PK. Exercise Reduces Dopamine D1R and Increases D2R in Rats: implications for addiction. Med Sci Sports Exerc. 2018;50(8):1596–602.PubMedCrossRef Robison LS, Swenson S, Hamilton J, Thanos PK. Exercise Reduces Dopamine D1R and Increases D2R in Rats: implications for addiction. Med Sci Sports Exerc. 2018;50(8):1596–602.PubMedCrossRef
51.
go back to reference Bardo MT, Compton WM. Does physical activity protect against drug abuse vulnerability? Drug Alcohol Depend. 2015;153:3–13.PubMedCrossRef Bardo MT, Compton WM. Does physical activity protect against drug abuse vulnerability? Drug Alcohol Depend. 2015;153:3–13.PubMedCrossRef
52.
go back to reference Peterson AB, Abel JM, Lynch WJ. Dose-dependent effects of wheel running on cocaine-seeking and prefrontal cortex Bdnf exon IV expression in rats. Psychopharmacology. 2013;231(7):1305–14.PubMedCrossRef Peterson AB, Abel JM, Lynch WJ. Dose-dependent effects of wheel running on cocaine-seeking and prefrontal cortex Bdnf exon IV expression in rats. Psychopharmacology. 2013;231(7):1305–14.PubMedCrossRef
53.
go back to reference Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652–69.PubMedPubMedCentralCrossRef Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652–69.PubMedPubMedCentralCrossRef
54.
go back to reference Wang J, Zou Z. Establishment of a biomarker of peripheral stress in opioid addicts based on the hypothalamic-pituitary-adrenal axis—The improvement effect of exercise. Front Psychiatry. 2022;13:1072896.PubMedPubMedCentralCrossRef Wang J, Zou Z. Establishment of a biomarker of peripheral stress in opioid addicts based on the hypothalamic-pituitary-adrenal axis—The improvement effect of exercise. Front Psychiatry. 2022;13:1072896.PubMedPubMedCentralCrossRef
55.
go back to reference Che X, Cai J, Liu Y, Xu T, Yang J, Wu C. Oxytocin signaling in the treatment of drug addiction: therapeutic opportunities and challenges. Pharmacol Ther. 2021;223:107820.PubMedCrossRef Che X, Cai J, Liu Y, Xu T, Yang J, Wu C. Oxytocin signaling in the treatment of drug addiction: therapeutic opportunities and challenges. Pharmacol Ther. 2021;223:107820.PubMedCrossRef
56.
go back to reference Armario A. Activation of the hypothalamic–pituitary–adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci. 2010;31(7):318–25.PubMedCrossRef Armario A. Activation of the hypothalamic–pituitary–adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci. 2010;31(7):318–25.PubMedCrossRef
Metadata
Title
Analysis of physical activity and prescription opioid use among US adults: a cross-sectional study
Authors
Junpeng Wu
Panpan Yang
Xiaodan Wu
Xiaoxuan Yu
Fanfang Zeng
Haitang Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18220-7

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue